Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹1,852.20
Market cap: ₹4,44,405 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 36.7×Sector 50.4×
Promoter holding: 54.48%+0.00% QoQ
FII holding: 14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 9 Financial Results 3 Promoter Reclassification 1 Merger & Restructuring 1 Legal & Regulatory 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

31 Jul 2026 14:29 IST BSE

Financial Results

Sun Pharmaceutical Industries Q1 FY27 Results: Net Profit ₹2,895 Cr, Up 27.0% YoY

Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹15,300 Cr (+10.5% YoY) and net profit of ₹2,895 Cr (+27.0% YoY) for Q1 FY27.

Key figure: Net profit ₹2,895 Cr · +27.0% YoY

Open full results → Read the filing ↗

22 May 2026 14:55 IST BSE

Financial Results

Sun Pharmaceutical Industries Q4 FY26 Results: Net Profit ₹2,714 Cr, Up 26.2% YoY

Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹14,612 Cr (+12.8% YoY) and net profit of ₹2,714 Cr (+26.2% YoY) for Q4 FY26.

Key figure: Net profit ₹2,714 Cr · +26.2% YoY

Open full results → Read the filing ↗

22 May 2026 14:45 IST NSE

Financial Results

Sun Pharmaceutical Industries Q4 FY26 Results: Net Profit ₹2,724 Cr, Up 26.1% YoY

Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹14,612 Cr (+12.8% YoY) and net profit of ₹2,724 Cr (+26.1% YoY) for Q4 FY26.

Key figure: Net profit ₹2,724 Cr · +26.1% YoY

Open full results → Read the filing ↗